Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis.
Saved in:
| Title: | Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis. |
|---|---|
| Authors: | Hartman DS; Avaxia Biologics, Inc., Lexington, MA, USA., Tracey DE; Avaxia Biologics, Inc., Lexington, MA, USA., Lemos BR; Avaxia Biologics, Inc., Lexington, MA, USA., Erlich EC; Avaxia Biologics, Inc., Lexington, MA, USA., Burton RE; Avaxia Biologics, Inc., Lexington, MA, USA., Keane DM; Avaxia Biologics, Inc., Lexington, MA, USA., Patel R; Avaxia Biologics, Inc., Lexington, MA, USA., Kim S; Avaxia Biologics, Inc., Lexington, MA, USA., Bhol KC; Avaxia Biologics, Inc., Lexington, MA, USA., Harris MS; Avaxia Biologics, Inc., Lexington, MA, USA., Fox BS; Avaxia Biologics, Inc., Lexington, MA, USA bsfox@comcast.net. |
| Source: | Journal of Crohn's & colitis [J Crohns Colitis] 2016 Jun; Vol. 10 (6), pp. 641-9. Date of Electronic Publication: 2016 Jan 22. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-4479 (Electronic) Linking ISSN: 18739946 NLM ISO Abbreviation: J Crohns Colitis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26802087 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hartman+DS%22">Hartman DS</searchLink>; Avaxia Biologics, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tracey+DE%22">Tracey DE</searchLink>; Avaxia Biologics, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lemos+BR%22">Lemos BR</searchLink>; Avaxia Biologics, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Erlich+EC%22">Erlich EC</searchLink>; Avaxia Biologics, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Burton+RE%22">Burton RE</searchLink>; Avaxia Biologics, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Keane+DM%22">Keane DM</searchLink>; Avaxia Biologics, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Patel+R%22">Patel R</searchLink>; Avaxia Biologics, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; Avaxia Biologics, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bhol+KC%22">Bhol KC</searchLink>; Avaxia Biologics, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Harris+MS%22">Harris MS</searchLink>; Avaxia Biologics, Inc., Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fox+BS%22">Fox BS</searchLink>; Avaxia Biologics, Inc., Lexington, MA, USA bsfox@comcast.net. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101318676%22">Journal of Crohn's & colitis</searchLink> [J Crohns Colitis] 2016 Jun; Vol. 10 (6), pp. 641-9. <i>Date of Electronic Publication: </i>2016 Jan 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101318676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1876-4479 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218739946%22">18739946 </searchLink><i>NLM ISO Abbreviation: </i>J Crohns Colitis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26802087 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/ecco-jcc/jjw026 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 641 Titles: – TitleFull: Effects of AVX-470, an Oral, Locally Acting Anti-Tumour Necrosis Factor Antibody, on Tissue Biomarkers in Patients with Active Ulcerative Colitis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hartman DS – PersonEntity: Name: NameFull: Tracey DE – PersonEntity: Name: NameFull: Lemos BR – PersonEntity: Name: NameFull: Erlich EC – PersonEntity: Name: NameFull: Burton RE – PersonEntity: Name: NameFull: Keane DM – PersonEntity: Name: NameFull: Patel R – PersonEntity: Name: NameFull: Kim S – PersonEntity: Name: NameFull: Bhol KC – PersonEntity: Name: NameFull: Harris MS – PersonEntity: Name: NameFull: Fox BS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2016 Jun Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1876-4479 Numbering: – Type: volume Value: 10 – Type: issue Value: 6 Titles: – TitleFull: Journal of Crohn's & colitis Type: main |
| ResultId | 1 |